Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
Assay Kits
Assay Kit
FluoroSpot Plus: Human IFN-γ (550)
Supplier Images
FluoroSpot Plus: Human IFN-gamma (550)
FluoroSpot Plus: Human IFN-γ (550) from Mabtech AB
Be the first to write a review!
Citations:
(18)
Supplier Page
Supplier Page from
Mabtech AB for
FluoroSpot Plus: Human IFN-γ (550)
Description
The single-analyte FluoroSpot assay provides an ELISpot alternative with fluorescent detection instead of enzymatic. The assay enables enumeration of cells secreting human Interferon-gamma (IFN-γ)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
FluoroSpot Plus: Human IFN-γ (550)
Company
Mabtech AB
Price
$2,640.00
Supplier Page
View Company Product Page
Catalog Number
FSP-01B-10
Quantity
10 plate
Applications
FluoroSpot
Reactivity
human
Detection Target
IFN-γ
NCBI Full Gene Name
interferon gamma
NCBI Gene Aliases
IFG, IFI, IMD69
Format
pre-coated plates
Components
Biotinylated detection mAb (7-B6-1),SA-550,Anti-CD3 mAb,Anti-CD28 mAb (CD28-A),FluoroSpot enhancer,Pre-coated FluoroSpot plates (mAb 1-D1K)
Add to Compare List
Mabtech AB
Box 1233
Nacka Strand
,
SE-131 28
Sweden
Phone
: +46 8 716 27 00
+46 8 716 27 01
Company Profile
Website:
http://www.mabtech.com
Citations (18)
(1)
Impact of SARS-CoV-2 variants on the total CD4
+
and CD8
+
T cell reactivity in infected or vaccinated individuals
Cell reports. Medicine
July 20, 2021
Tarke A, Sidney J, Methot N, Yu ED, Zhang Y, Dan JM, Goodwin B, Rubiro P, Sutherland A, Wang E,
et al
.
(2)
Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge study
The Lancet. Infectious diseases
April 1, 2020
Liebowitz D, Gottlieb K, Kolhatkar NS, Garg SJ, Asher JM, Nazareno J, Kim K, McIlwain DR, Tucker SN.
(3)
Human Immunodeficiency Virus Exposure but Not Early Cytomegalovirus Infection Is Associated With Increased Hospitalization and Decreased Memory T-Cell Responses to Tetanus Vaccine
The Journal of infectious diseases
March 16, 2020
Smith C, Moraka NO, Ibrahim M, Moyo S, Mayondi G, Kammerer B, Leidner J, Gaseitsiwe S, Li S, Shapiro R,
et al
.
(4)
Myelin oligodendrocyte glycoprotein revisited-sensitive detection of MOG-specific T-cells in multiple sclerosis
Journal of autoimmunity
August 1, 2019
Bronge M, Ruhrmann S, Carvalho-Queiroz C, Nilsson OB, Kaiser A, Holmgren E, Macrini C, Winklmeier S, Meinl E, Brundin L,
et al
.
(5)
Variability in German Cockroach Extract Composition Greatly Impacts T Cell Potency in Cockroach-Allergic Donors
Frontiers in immunology
January 1, 2019
Birrueta G, Frazier A, Pomés A, Glesner J, Filep S, Schal C, Jeong KY, McMurtrey C, Vander Schans T, Hildebrand WH,
et al
.
(6)
Memory B Cells Activate Brain-Homing, Autoreactive CD4
+
T Cells in Multiple Sclerosis
Cell
September 20, 2018
Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K,
et al
.
(7)
Strong and frequent T-cell responses to the minor allergen Phl p 12 in Spanish patients IgE-sensitized to Profilins
Allergy
May 1, 2018
Lund G, Brand S, Ramos T, Jimeno L, Boissy P, Vega F, Arina M, Christensen LH, Hoof I, Meno KH,
et al
.
(8)
Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation
Oncotarget
April 17, 2018
Fostier K, Caers J, Meuleman N, Broos K, Corthals J, Thielemans K, Schots R, De Keersmaecker B.
(9)
Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopes
Oncotarget
January 12, 2018
Bieling M, Tischer S, Kalinke U, Blasczyk R, Buus S, Maecker-Kolhoff B, Eiz-Vesper B.
(10)
Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopes
PloS one
January 1, 2018
Carrasco Pro S, Lindestam Arlehamn CS, Dhanda SK, Carpenter C, Lindvall M, Faruqi AA, Santee CA, Renz H, Sidney J, Peters B,
et al
.
(11)
The effect of acylation with fatty acids and other modifications on HLA class II:peptide binding and T cell stimulation for three model peptides
PloS one
January 1, 2018
Schultz HS, Østergaard S, Sidney J, Lamberth K, Sette A.
(12)
Antigen delivery to dendritic cells shapes human CD4+ and CD8+ T cell memory responses to Staphylococcus aureus
PLoS pathogens
May 1, 2017
Uebele J, Stein C, Nguyen MT, Schneider A, Kleinert F, Tichá O, Bierbaum G, Götz F, Bekeredjian-Ding I.
(13)
Markers of Protection in Children and Adolescents Six to Fourteen Years After Primary Hepatitis B Vaccination in Real Life: A Pilot Study
The Pediatric infectious disease journal
March 1, 2016
Brunskole Hummel I, Huber B, Wenzel JJ, Jilg W.
(14)
Characteristics of immune memory 10-15 years after primary hepatitis B vaccination
Vaccine
January 27, 2016
Brunskole Hummel I, Zitzmann A, Erl M, Wenzel JJ, Jilg W.
(15)
Stepping up ELISpot: Multi-Level Analysis in FluoroSpot Assays
Cells
November 27, 2014
Janetzki S, Rueger M, Dillenbeck T.
(16)
Decreased functional T lymphocyte-mediated cytokine responses in patients with chemotherapy-induced neutropenia
Journal of internal medicine
October 1, 2013
L Öhrmalm, C Smedman, M Wong, K Broliden, T Tolfvenstam, O Norbeck
(17)
Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age
PloS one
January 1, 2013
Han WG, van Twillert I, Poelen MC, Helm K, van de Kassteele J, Verheij TJ, Versteegh FG, Boog CJ, van Els CA.
(18)
Human infant respiratory syncytial virus (RSV)-specific type 1 and 2 cytokine responses ex vivo during primary RSV infection
The Journal of infectious diseases
June 15, 2007
Lee FE, Walsh EE, Falsey AR, Lumb ME, Okam NV, Liu N, Divekar AA, Hall CB, Mosmann TR.
<<
<
>
>>
Reviews
Be the First to Write a Review!
FluoroSpot Plus: Human IFN-γ (550) from Mabtech AB
Supplier Page
View Company Product Page
$2,640.00
Product Specs
Company Info
Citations
Reviews
Back To Top